ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
2,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
3,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,3,Headache,Headaches NEC,Headaches,Nerv,N
4,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
6,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,3,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
6,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,6,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
7,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
8,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
10,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
10,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
15,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
17,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
18,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
20,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
20,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
22,2,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
23,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
23,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
25,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
25,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
27,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
28,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
30,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
33,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
33,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
33,3,Respiratory fume inhalation disorder,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
34,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
34,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
34,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
35,1,Chemical burn of oral cavity,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
35,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
35,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
35,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
35,5,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
35,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
35,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
35,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
36,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
36,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
36,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
36,4,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
37,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
37,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
38,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
40,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
40,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
40,3,Product counterfeit,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
40,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
40,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
41,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
41,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
41,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
42,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
42,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
42,3,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
43,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
43,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
44,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
44,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
45,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
45,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
45,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
45,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
45,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
46,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
47,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
47,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
48,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
48,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
49,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
49,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
49,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
49,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
49,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
50,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
51,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
52,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
52,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
52,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
52,4,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
52,5,Application site pain,Application site reactions,Administration site reactions,Genrl,N
52,6,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
52,7,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
52,8,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
53,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
53,2,Headache,Headaches NEC,Headaches,Nerv,N
53,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
53,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
54,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
54,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
54,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
55,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
55,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
56,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
56,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
56,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
56,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
57,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
57,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
58,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
59,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
60,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
60,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
60,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
60,4,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
60,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
60,6,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
61,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
61,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
61,3,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
62,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
62,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
62,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
63,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
63,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
63,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
63,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
63,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
63,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
63,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
64,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
64,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
65,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
65,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
66,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
67,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
67,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
68,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
68,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
69,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
71,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
71,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
72,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
72,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
73,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
73,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
74,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
74,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
74,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
75,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
76,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
77,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
77,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
77,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
77,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
78,1,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
78,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
78,3,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
78,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
79,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
79,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
79,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
79,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
79,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
79,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
80,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
80,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
80,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
80,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
80,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
80,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
81,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
83,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
84,2,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
85,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
85,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
86,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
87,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
88,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
88,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
89,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
91,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
92,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
92,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
92,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
92,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
92,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
93,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
94,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
94,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
95,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
95,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
95,4,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
95,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
96,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
96,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
97,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
98,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
98,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
98,3,Intentional product misuse to child,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
99,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
100,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
100,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
100,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
100,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
100,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
101,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
101,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
101,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
101,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
101,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
101,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
102,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
102,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
102,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
102,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
103,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
103,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
103,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
103,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
104,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
104,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
105,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
105,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
106,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
106,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
106,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
106,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
107,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
107,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
108,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
108,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
109,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
110,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
110,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
110,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
111,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
111,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
111,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
111,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
112,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,2,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
112,3,Nasal mucosal blistering,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
113,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
113,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
114,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
114,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
114,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
115,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
115,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
115,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
116,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
116,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
116,3,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
116,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
116,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
117,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
117,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
117,4,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
117,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
117,6,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
